We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£139.00
It has never been this cheap. We have no record of a lower price.
£139 today · cheaper than every other day in the last 3 months
Springer Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 31 days · 31 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 31 days • 2 price levels
Current Price
Price Analysis
Most common price: £160 (30 days, 96.8%)
Price range: £139 - £160
Price levels: 2 different prices over 31 days
Description
This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 1461432081
- Domain
- Amazon UK
- Release Date
- 25 March 2014
- Listed Since
- 16 December 2011
Barcode
No barcode data available
Similar Products You Might Like
99% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology)
Springer
£203.36
25 Aug 2026
99% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)
Springer
£203.36
25 Aug 2026
99% match
Retinal Degenerative Diseases XIX: Mechanisms and Experimental Therapy: 1415 (Advances in Experimental Medicine and Biology, 1415)
Springer
£277.72
23 Oct 2026
99% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy
Springer
£139.01
22 Oct 2026
98% match
New Insights Into Retinal Degenerative Diseases
Springer
£77.28
23 Sep 2026
98% match
Mouse Retinal Phenotyping: Methods and Protocols - Volume 1753
Humana
£121.46
05 Oct 2026
97% match
Mouse Retinal Phenotyping: Methods and Protocols: 1753 (Methods in Molecular Biology, 1753)
Humana
£118.34
27 Aug 2026
97% match
Animal Models for Retinal Diseases: 46 (Neuromethods, 46)
Humana
£103.27
17 Sep 2026
97% match
Retinal Gene Therapy: Methods and Protocols: 1715 (Methods in Molecular Biology, 1715)
Humana
£54.58
10 Oct 2026
97% match
Concepts and Challenges in Retinal Biology (Volume 131) (Progress in Brain Research, Volume 131)
Elsevier
£36.95
26 Aug 2026
97% match
Recent Advances In Retinal Degeneration: 613 (Advances in Experimental Medicine and Biology, 613)
Springer
£147.14
24 Sep 2026
97% match
Retinal Degenerative Diseases: 723 (Advances in Experimental Medicine and Biology, 723)
Springer
£199.99
06 Oct 2026
97% match
Neuroprotection and Neuroregeneration for Retinal Diseases
Springer
£103.24
03 Oct 2026
97% match
Retinal Degeneration: Methods and Protocols - Volume 935
Humana
£101.40
05 Oct 2026
97% match
Rétine: Coffret Produits
£272.09
25 Aug 2026
97% match
Retinal Degenerations: Mechanisms and Experimental Therapy: 533 (Advances in Experimental Medicine and Biology, 533)
Springer
£148.27
21 Aug 2026
97% match
Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)
Springer
£203.36
19 Aug 2026
97% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
Springer
£227.29
23 Aug 2026
97% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
Springer
£233.25
21 Aug 2026
97% match
Recent Advances in Ophthalmology Research (Eye and Vision Research Developments)
£58.84
30 Sep 2026
97% match
Retinal Degeneration: Clinical and Laboratory Applications - Proceedings of an International Symposium Held in Costa Smeralda, Sardinia, September 15-20, 1992
Springer
£77.63
02 Oct 2026
97% match
Visual Dysfunction in Diabetes: The Science of Patient Impairment and Health Care (Ophthalmology Research)
Humana
£107.85
02 Oct 2026
97% match
Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)
Springer
£203.36
26 Aug 2026
97% match
Retinal Degeneration: Methods and Protocols: 1834 (Methods in Molecular Biology, 1834)
Humana
£119.41
12 Aug 2026